Chr. Hansens konsensus estimater for Q1 21/22 og for hele året.
| Estimates (EUR million) | Q1 2021/22 | FY 2021/22 | FY 2022/23 | FY 2023/24 | ||||
| Consensus | Consensus | Consensus | Consensus | |||||
| Total revenue | 255 | 1.155 | 1.232 | 1.318 | ||||
| – FC&E | 174 | 743 | 782 | 825 | ||||
| – H&N | 81 | 412 | 450 | 493 | ||||
| Organic growth | 4,4% | 6,3% | 6,6% | 6,9% | ||||
| – FC&E | 5,6% | 5,4% | 5,3% | 5,5% | ||||
| – H&N | 1,8% | 8,1% | 9,1% | 9,5% | ||||
| EBITDA b.s.i. | 90 | 428 | 463 | 503 | ||||
| – FC&E | 67 | 295 | 313 | 331 | ||||
| – H&N | 23 | 133 | 152 | 173 | ||||
| EBITDA b.s.i. | 35,4% | 37,0% | 37,5% | 38,1% | ||||
| – FC&E | 38,7% | 39,6% | 39,8% | 40,0% | ||||
| – H&N | 28,8% | 32,3% | 33,7% | 35,0% | ||||
| EBIT b.s.i. | 64 | 320 | 352 | 387 | ||||
| – FC&E | 53 | 237 | 253 | 269 | ||||
| – H&N | 11 | 83 | 99 | 118 | ||||
| EBIT margin b.s.i. | 25,0% | 27,7% | 28,5% | 29,4% | ||||
| – FC&E | 30,3% | 31,9% | 32,3% | 32,6% | ||||
| – H&N | 13,6% | 20,1% | 22,0% | 24,0% | ||||
| Special items | 0 | 0 | 0 | 0 | ||||
| EBIT | 64 | 320 | 351 | 387 | ||||
| Net financial items | -4 | -17 | -16 | -15 | ||||
| Share of loss of JV | -2 | -5 | -2 | 0 | ||||
| Tax | -13 | -67 | -75 | -84 | ||||
| Net profit | 44 | 231 | 259 | 289 | ||||
| FCF b.s.i. | 159 | 210 | 247 | |||||
| Capex | -158 | -149 | -142 | |||||
| Net debt | 882 | 833 | 773 | |||||
| EPS, Group | 0,34 | 1,75 | 1,96 | 2,19 | ||||
| Tax | 22,7% | 22,5% | 22,5% | 22,5% | ||||
| WACC | 6,0% | |||||||
| Target price | 524 | |||||||
| Implied share count, mio | 132 | 132 | 132 | 132 | ||||
| Datapoint count | 15 | 15 | 15 | 15 |
